Mizuho Securities Downgrades AcelRx Pharmaceuticals (ACRX) to Neutral
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Mizuho Securities downgraded AcelRx Pharmaceuticals (NASDAQ: ACRX) from Outperform to Neutral with a price target of $6.00 (from $15.00).
For an analyst ratings summary and ratings history on AcelRx Pharmaceuticals click here. For more ratings news on AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $6.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Johnson Matthey PLC (JMAT:LN) (JMPLY) PT Raised to GBP21.70 at Barclays
- Centamin Plc. (CEY:LN) (CELTF) PT Raised to GBP1.50 at Canaccord Genuity
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
